Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01801891
Other study ID # VASGARD2013
Secondary ID
Status Completed
Phase Phase 2
First received February 25, 2013
Last updated December 11, 2014
Start date May 2013
Est. completion date October 2014

Study information

Verified date December 2014
Source Mid Western Regional Hospital, Ireland
Contact n/a
Is FDA regulated No
Health authority Ireland: Research Ethics Committee
Study type Interventional

Clinical Trial Summary

This study aims to determine if the use of surface neuromuscular electrical stimulation, applied to various motor points on the lower limb to elicit muscle contraction when combined with compression bandaging accelerates the rate of venous leg ulcer healing.


Description:

With an increasingly ageing population the incidence of venous ulceration is likely to rise. The negative impact of leg ulceration on patients' quality of life and on healthcare costs is well recognised. Increased prevalence combined with poor reported healing rates and high incidence of ulcer recurrence makes the development of a new treatment which could accelerate healing rates beyond that currently achieved using compression bandaging most desirable. Surface neuromuscular electrical stimulation in combination with compression bandaging may provide such a treatment.

Surface neuromuscular electrical stimulation (SNMES) is the application of an electrical stimulus to motor points in the body using electrodes placed on the surface of the skin to elicit a muscular contraction. It has been shown that SNMES of the calf muscles, when used in conjunction with compression therapy, provides improved venous flow velocities over compression therapy alone. Furthermore, the week-long effect of SNMES and compression therapy on healthy participants was found to be well tolerated by all participants and resulted in increases in stimulated venous flow and muscle strength. A combined SNMES and compression treatment protocol which stimulates peripheral venous blood flow may help to alleviate harmful venous pressures in venous leg ulcer patients and provide some degree of strengthening of the calf muscles, thus helping to accelerate the healing rates of venous ulcers.


Recruitment information / eligibility

Status Completed
Enrollment 25
Est. completion date October 2014
Est. primary completion date September 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Primary or recurrent venous leg ulcer.

- Ankle-brachial pressure index > 0.8

- Ulcer size between 1 and 200 cm2

- Patient suitable for full compression bandaging

Exclusion Criteria:

- History of symptomatic heart disease.

- Pregnancy

- Presence of implants in the lower leg or a pacemaker

- History of a neurological disorder

- Presence of any contraindications for the use of compression stockings such as severe arterial disease i.e. Ankle brachial pressure index (ABPI) <0.8

- Presence of cognitive difficulties which may prevent the patient or his/her carer from using the stimulator appropriately.

- Patients unable to provide informed consent

- Patients receiving dialysis

- Patients receiving steroids

- Patients receiving methotrexate

- Ulcer located in the area of electrode placement

- Patients in reduced compression bandaging system

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
VASGARD stimulator
The VASGARD device is a 2 channel muscle stimulator system designed for increasing venous blood flow. Controlled electrical stimuli are delivered to the patient through adhesive gel electrodes placed over the motor points of muscles on the lower leg. This elicits artificial muscular contractions which in turn increases lower limb venous haemodynamics.
Other:
Compression bandaging
Compression bandaging systems apply graduated external pressure to the lower limb to promote venous return to the heart reducing venous hypertension and thereby facilitate venous ulcer healing.

Locations

Country Name City State
Ireland Department of Electronic Engineering, National University Ireland Galway Galway
Ireland MidWestern Regional Hospital Limerick

Sponsors (1)

Lead Sponsor Collaborator
Professor Stewart Walsh

Country where clinical trial is conducted

Ireland, 

Outcome

Type Measure Description Time frame Safety issue
Other Changes in skin condition related to the application of Vasgard surface neuromuscular electrical stimulator as a measure of safety and tolerability. The safety issues associated with using electrical stimulation on this patient group under compression bandaging will be evaluated. The following safety points will be evaluated at each visit.
Appearance of the skin under the electrodes (intact / reddened / broken)
Appearance of skin surrounding the electrodes (intact / reddened /broken)
Appearance of skin under the electrodes leads (intact / reddened / broken
12 weeks Yes
Primary Reduction in venous ulcer size Reduction in relative ulcer size (area) for each patient over time, standardised to an initial size of 1, will be measured weekly. 12 weeks No
Secondary Acceptability of surface neuromuscular electrical stimulation Patient and healthcare provider perceptions of the acceptability, efficacy and tolerability of the device will be evaluated through a series of semi-structured interviews 12 weeks No
See also
  Status Clinical Trial Phase
Recruiting NCT00766974 - Compression Aided Management of Edema in Patients With C3 Venous Disease Phase 4
Recruiting NCT05005052 - Sulodexide in the Treatment of Chronic Primary Venous Disease of the Lower Extremities Phase 3
Completed NCT04101201 - Clinical Trial to Assess the Efficacy of µSmin® Plus N/A
Not yet recruiting NCT04901845 - VEIN Health - CVD Prevalence and Characteristics
Not yet recruiting NCT06318988 - Outcomes of Different Treatment Options in Chronic Venous Disease
Completed NCT04574375 - Chronic VEnous dIsorders maNagement and Treatment effectivenesS evaluaTion in Chronic vEnous Disease, an International Program
Completed NCT04310280 - Effects of Local Insulin on Varicose Ulcers for Wound Healing Phase 3
Recruiting NCT04882228 - Phase 4 Study to Evaluate Efficacy and Safety of Entelon Tab.150mg in Patients With Chronic Venous Disease(CVD) Phase 4
Completed NCT03722836 - Evaluation of the Efficacy and Tolerability of Detralex in Patients With Chronic Venous Edema in Real Clinical Practice
Not yet recruiting NCT05612217 - Evaluation of the AIVARIX in Detecting Signs C 1-2 Classes of CVD
Completed NCT02137499 - Venous Insufficiency and Neuromuscular Stimulation N/A